Publications internationales

  F. Brossier, C. Sola, G. Millot, V. Jarlier, N. Veziris, et W. Sougakoff. Comparison of a semi-automated commercial rep-PCR method with spoligotyping, 24-locus-MIRU-VNTR and IS6110-RFLP for Mycobacterium tuberculosis typing. J. Clin. Microbiol. Nov ; 52(11) : 4082-6. 2014.
  T. V. Bui, V. Meyssonnier, P. Y. Boelle, D. Che, D. Antoine, V. Jarlier, et J. Robert. Decrease in the incidence of culture-positive meningitis and cerebral tuberculomas in France from 1990 to 2007. Epidemiol. Infect., vol. 142, no 7, p. 1510-1516, juill. 2014.
  I. Lerat, E. Cambau, R. Roth Dit Bettoni, J.-L. Gaillard, V. Jarlier, C. Truffot, et N. Veziris. In vivo evaluation of antibiotic activity against Mycobacterium abscessus. J. Infect. Dis., vol. 209, no 6, p. 905-912, mars 2014.
  E. Macheras, J. Konjek, A.-L. Roux, J.-M. Thiberge, S. Bastian, S. C. Leão, M. Palaci, V. Sivadon-Tardy, C. Gutierrez, E. Richter, S. Rüsch-Gerdes, G. E. Pfyffer, T. Bodmer, V. Jarlier, E. Cambau, S. Brisse, V. Caro, N. Rastogi, J.-L. Gaillard, B. Heym. Multilocus sequence typing scheme for the Mycobacterium abscessus complex. Res. Microbiol., vol. 165, no 2, p. 82-90, mars 2014.
  A.-L. Roux, E. Catherinot, N. Soismier, B. Heym, G. Bellis, L. Lemonnier, R. Chiron, B. Fauroux, M. Le Bourgeois, A. Munck, I. Pin, I. Sermet, C. Gutierrez, N. Véziris, V. Jarlier, E. Cambau, J.-L. Herrmann, D. Guillemot, J.-L. Gaillard, for the OMA group. Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients. J Cyst Fibros. 2015 Jan ;14(1):63-9..
  Delafont V, Mougari F, Cambau E, Joyeux M, Bouchon D, Héchard Y, Moulin L. First evidence of amoebae-mycobacteria association in drinking water network. Environ Sci Technol. 2014 Oct 21 ;48(20):11872-82.
  Fangous MS, Mougari F, Gouriou S, Calvez E, Raskine L, Cambau E, Payan C, Héry-Arnaud G. Classification algorithm for subspecies identification within the Mycobacterium abscessus species, based on matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol. 2014 Sep ;52(9):3362-9.
  Mougari F, Raskine L, Ferroni A, Marcon E, Sermet-Gaudelus I, Veziris N, Heym B, Gaillard JL, Nassif X, Cambau E. Clonal relationship and differentiation among Mycobacterium abscessus isolates as determined using the semiautomated repetitive extragenic palindromic sequence PCR-based DiversiLab system. J Clin Microbiol. 2014 Jun ;52(6):1969-77.
  Macheras E, Konjek J, Roux AL, Thiberge JM, Bastian S, Leão SC, Palaci M, Sivadon-Tardy V, Gutierrez C, Richter E, Rüsch-Gerdes S, Pfyffer GE, Bodmer T, Jarlier V, Cambau E, Brisse S, Caro V, Rastogi N, Gaillard JL, Heym B. Multilocus sequence typing scheme for the Mycobacterium abscessus complex. Res Microbiol. 2014 Feb-Mar ;165(2):82-90.
  Guglielmetti L, Le Dû D, Jachym M, Henry B, Martin D, Caumes E, Veziris N, Métivier N, Robert J. MDR-TB Management Group of the French National Reference Center for Mycobacteria and the Physicians of the French MDR-TB Cohort. Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis : interim analysis of a French cohort. Clin Infect Dis. 2015 Jan 15 ;60(2):188-94.
  Renvoisé A, Bernard C, Veziris N, Galati E, Jarlier V, Robert J. Significant difference in drug susceptibility distribution between Mycobacterium avium and Mycobacterium intracellulare. J Clin Microbiol. 2014 Dec ;52(12):4439-40.
 . Ycart B, Veziris N. Unbiased estimation of mutation rates under fluctuating final counts. PLoS One. 2014 Jul 2 ;9(7):e101434.
  Atallah D, El Kassis N, Araj G, Nasr M, Nasnas R, Veziris N, Sarkis D. Mycobacterial infection of breast prosthesis—a conservative treatment : a case report. BMC Infect Dis. 2014 May 5 ;14:238.
  de Masson A, Maillart E, Veziris N, Meyssonnier V, Papeix C, Caumes E. Cavitary pulmonary disease in a patient treated with natalizumab. Presse Med. 2014 Sep ;43(9):1009-12.
  Aubry A, Sougakoff W, Bodzongo P, Delcroix G, Armand S, Millot G, Jarlier V, Courcol R, Lemaître N. First evaluation of drug-resistant Mycobacterium tuberculosis clinical isolates from Congo revealed misdetection of fluoroquinolone resistance by line probe assay due to a double substitution T80A-A90G in GyrA. PLoS One. 2014 Apr 17 ;9(4):e95083.
  Godreuil S, Leban N, Padilla A, Hamel R, Luplertlop N, Chauffour A, Vittecoq M, Hoh F, Thomas F, Sougakoff W, Lionne C, Yssel H, Missé D. Aedesin : structure and antimicrobial activity against multidrug resistant bacterial strains. PLoS One. 2014 Aug 27 ;9(8):e105441.
  Renvoisé A, Pang S, Bernard C, Brossier F, Veziris N, Capton E, Jarlier V, Sougakoff W. First whole-genome sequence of a clinical isolate of multi-drug resistant Mycobacterium bovis BCG. Genome Announc. 2014 Jul 10 ;2(4). pii : e00611-14
  Bernard C, Brossier F, Fréchet-Jachym M, Morand PC, Coignard S, Aslangul E, Aubry A, Jarlier V, Sougakoff W, Veziris N. Concomitant multidrug-resistant pulmonary tuberculosis and susceptible tuberculous meningitis. Emerg Infect Dis. 2014 Mar ;20(3):506-7.
  Cambau E, Drancourt M. Steps towards the discovery of Mycobacterium tuberculosis by Robert Koch, 1882. Clin Microbiol Infect. 2014 Mar ;20(3):196-201. doi : 10.1111/1469-0691.12555.

  Publications nationales

  A. Renvoisé, C. Bernard. Traitement des infections à Mycobacterium avium complex. J Anti-Infect. 2014 ;16 :199-206
  J. Robert, « Rapport d’activité 2011-12 de l’ONERBA / Annual Report 2011-12 (Observatoire National de l’Epidémiologie de la Résistance Bactérienne aux Antibiotiques). 2014. 188 pages (http://www.onerba.org) »
  J. Robert. Résistance aux antibiotiques : un enjeu de développement durable et un impératif de surveillance. HygièneS 2014 ;22 :29-40.
  A. de Masson, E. Maillart, N. Veziris, V. Meyssonnier, C. Papeix, et E. Caumes, Cavitary pulmonary disease in a patient treated with natalizumab, Presse Med. 2014 Sep ;43(9):1009-12. .
  P. Mordant, B. Henry, S. Morel, J. Robert, N. Veziris, D. Le Dû, M. Frechet-Jachym, T. Similowski, É. Caumes, M. Riquet, et F. Le Pimpec-Barthes. Adjuvant surgical resection for multidrug-resistant tuberculosis : A review, Rev Mal Respir, vol. 31, no 6, p. 511-524, 2014.
  Mougari F, Cambau E. Mycobactéries et eau, Revue Francophone des Laboratoires- Février 2014 - n°459

  Publications en tant que collaborateur d’études multicentriques

  M. L. Bastos, H. Hussain, K. Weyer, L. Garcia-Garcia, V. Leimane, C. C. Leung, M. Narita, J. M. Penã, A. Ponce-de-Leon, K. J. Seung, K. Shean, J. Sifuentes-Osornio, M. Van der Walt, T. S. Van der Werf, W. W. Yew, D. Menzies, Collaborative Group for Meta-analysis of Individual Patient Data in MDR-TB. Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs : an individual patient data meta-analysis. Clin. Infect. Dis., vol. 59, no 10, p. 1364-1374, nov. 2014.
  J. De Beer, C. Kodmon, M. van der Werf, J. van Ingen, D. van Soolingen, ECDC MDR-TB molecular surveillance project participants. Molecular surveillance of multi- and extensively drug-resistant tuberculosis transmission in the European Union from 2003 to 2011. Euro Surveill., vol. 19, no 11, 2014.
  J. L. de Beer, C. Ködmön, J. van Ingen, P. Supply, D. van Soolingen, Global Network for Molecular - Surveillance of Tuberculosis 2010. Second worldwide proficiency study on variable number of tandem repeats typing of Mycobacterium tuberculosis complex. Int. J. Tuberc. Lung Dis., vol. 18, no 5, p. 594-600, mai 2014.